Article Versions Notes

Kim G, Moon H-k, Kim T, Yun S-h, Yun H-y, Hong JH, Kim D-D. Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study. Pharmaceutics. 2023; 15(9):2357. https://doi.org/10.3390/pharmaceutics15092357

Kim, Gwanyoung, Hyun-ki Moon, Taeheon Kim, So-hye Yun, Hwi-yeol Yun, Jang Hee Hong, and Dae-Duk Kim. 2023. "Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study" Pharmaceutics 15, no. 9: 2357. https://doi.org/10.3390/pharmaceutics15092357

Kim, G., Moon, H. -k., Kim, T., Yun, S. -h., Yun, H. -y., Hong, J. H., & Kim, D. -D. (2023). Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study. Pharmaceutics, 15(9), 2357. https://doi.org/10.3390/pharmaceutics15092357